Report cards › Companies › Regeneron Pharmaceuticals
Regeneron Pharmaceuticals: Political money and lobbying (shown, not graded) records
Political money and lobbying (shown, not graded): 111 records from the U.S. Senate Office of Public Records (LDA.gov), from 2021 to 2026; 92 of them list an amount, $14,490,000 in all. Political money and lobbying (shown, not graded): 3 records from the Federal Election Commission, from 2022 to 2026; the amounts total $587,500. Outcomes as recorded: $251,000.00 to federal candidates' committees (2025-2026) (1), $175,500.00 to federal candidates' committees (2023-2024) (1), $161,000.00 to federal candidates' committees (2021-2022) (1).
Newest first; records 51 to 100 of 114. Each links to the agency's own record. Back to the report card.
| Date | Agency | What the agency recorded | Amount or outcome | Record | Retrieved | Matched | Report |
|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $400,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 2670 | $400,000 · $400,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 17, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2024 (2nd Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $430,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 2670 | $430,000 · $430,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 17, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 4, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2024 (1st Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Feb 5, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 22, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $430,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 7900 | $430,000 · $430,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 16, 2024 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2023 (4th Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 31, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $400,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 7900, S. 954 | $400,000 · $400,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 16, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2023 (3rd Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $370,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 7900, S. 954 | $370,000 · $370,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 19, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 8, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2023 (2nd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $460,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 5376, H.R. 7900, S. 954 | $460,000 · $460,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 17, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2023 (1st Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $320,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 5376, H.R. 7900, S. 4348, H.R. 7667, S. 3799 | $320,000 · $320,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 18, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported $10,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues CPT, MMM | $10,000 · $10,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 10, 2023 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2022 (4th Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Dec 31, 2022 | Federal Election Commission | FEC: REGENERON PHARMACEUTICALS, INC. PAC (committee C00562264; connected organization REGENERON PHARMACEUTICALS, INC.) reported $161,000.00 in contributions to federal candidates' committees in the 2021-2022 cycle, reports through 2022-12-31 | $161,000 · $161,000.00 to federal candidates' committees (2021-2022) | Source record | Oct 24, 2026 | matched by name | Report an error |
| Oct 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $320,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues CPT, HCR, MMM; bills named: H.R. 5376, H.R. 7900, S. 4348, H.R. 7667 | $320,000 · $320,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 18, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report (No Activity)) | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 4, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2022 (3rd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $340,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues CPT, HCR, MMM | $340,000 · $340,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 12, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues TRD | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jul 7, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 2nd Quarter (Apr 1 - June 30) of 2022 (2nd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $370,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues CPT, HCR, MMM | $370,000 · $370,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues HCR | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VENN STRATEGIES reported $100,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues HCR, TAX | $100,000 · $100,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 18, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues TRD | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Apr 11, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 1st Quarter (Jan 1 - Mar 31) of 2022 (1st Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: REGENERON PHARMACEUTICALS, INC reported $370,000.00 (expenses) for lobbying for REGENERON PHARMACEUTICALS, INC in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues CPT, HCR, MMM | $370,000 · $370,000.00 (expenses) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues HCR; bills named: H.R. 5376 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 20, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VENN STRATEGIES reported $100,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues HCR, TAX | $100,000 · $100,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 14, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: ARNOLD & PORTER KAYE SCHOLER LLP reported no amount for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues TRD | no amount | Source record | Oct 26, 2026 | matched by name | Report an error |
| Jan 2, 2022 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 4th Quarter (Oct 1 - Dec 31) of 2021 (4th Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: CRANE STRATEGIES reported $50,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues BUD | $50,000 · $50,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: STEWART STRATEGIES AND SOLUTIONS, LLC reported $60,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues HCR; bills named: H.R. 5376 | $60,000 · $60,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
| Oct 20, 2021 | U.S. Senate Office of Public Records (LDA.gov) | LDA: VENN STRATEGIES reported $100,000.00 (income) for lobbying for REGENERON PHARMACEUTICALS, INC. in the 3rd Quarter (July 1 - Sep 30) of 2021 (3rd Quarter - Report); issues HCR, TAX | $100,000 · $100,000.00 (income) | Source record | Oct 26, 2026 | matched by name | Report an error |
CSWH is not affiliated with these agencies.